Patents by Inventor Teruo Miyata

Teruo Miyata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4704131
    Abstract: The medical material contains heparinized collagen in which heparin has been bonded to protamine covalently fixed on collagen, and, owing to its excellent compatibility with living bodies, especially, its superb antithrombotic property, can be suitably used as a substituent material for tissues or organs which are brought into direct contact with blood, namely, as aritificial vessels, artificial valves and patching materials for cardiovascular organs, and the above medical material is also suitable as a membrane having anti-adhesion effects. The medical material is obtained by immersing and treating a natural or artificial material successively in an aqueous protamine solution, an aqueous glutaraldehyde solution and an aqueous heparin solution.
    Type: Grant
    Filed: October 15, 1984
    Date of Patent: November 3, 1987
    Assignee: Koken Co., Ltd.
    Inventors: Yasuharu Noishiki, Teruo Miyata
  • Patent number: 4695281
    Abstract: The medical material according to this invention contains collagen, which as been chemically modified by saccinylation of thermal --NH.sub.2 groups of said chains attached to poly peptide chains of the collagen so that the --NH.sub.2 groups are converted into groups having --COOH groups. This succinylation can be carried out by reacting succinic anhydride with the --NH.sub.2 groups of the collagen. Since the above medical material has excellent compatibility with living bodies, especially, with blood, it is suitable to use it as a replacement material for tissues and/or organs which are kept in contact with blood at their surfaces, namely, is suitable for use in artificial blood vessels, artificial valves, some parts of artificial hearts which are kept in contact with blood at said parts, etc. and as a patching material for hearts.
    Type: Grant
    Filed: March 25, 1983
    Date of Patent: September 22, 1987
    Assignee: Koken Co., Ltd.
    Inventors: Teruo Miyata, Yasuharu Noishiki
  • Patent number: 4690973
    Abstract: This invention concerns a production process of an antithrombogenic and antiadhesive material which can favorably be used as artificial blood vessels, artificial valves, grafting patches for cardiovascular organs, artificial heart catheters and so on. The gist of this invention is constructed substantially of subjecting glycidyltrialkylammonium halide such as glycidyltrimethylammonium chloride to the reaction with a material comprising pure collagen or collagen and other components like mucopolysaccharide in order to introduce a cationic quaternary functional group in collagen molecules of the material and then subjecting heparin to the ionic combination with the cationic functional group introduced.
    Type: Grant
    Filed: July 15, 1986
    Date of Patent: September 1, 1987
    Assignee: Koken Company Limited
    Inventors: Yasuharu Noishiki, Kazuhiko Kodaira, Masayasu Furuse, Teruo Miyata, Takeaki Miyamoto, Hiraku Ito
  • Patent number: 4687518
    Abstract: Pyrogen-free collagen useful for manufacturing soft contact lenses is made by performing all manufacturing process steps under aseptic conditions.
    Type: Grant
    Filed: November 6, 1985
    Date of Patent: August 18, 1987
    Assignee: Optical Corp.
    Inventors: Teruo Miyata, Albert L. Rubin
  • Patent number: 4642118
    Abstract: This invention concerns a double-layered man-made skin which is prepared by laminating a collagen sponge sheet and a poly-.alpha.-amino acid membrane that has a good affinity with tissue cells and an appropriate permeability for moisture. When the man-made skin is applied on burns, cuts or wounds, the fibroblasts proliferate in the collagen sponge sheet forming a three-dimensional structure, while the epidermal cells proliferate in the region between the poly-.alpha.-amino acid membrane and a collagen sponge sheet. The poly-.alpha.-amino acid membrane plays a role in protecting affected part and in providing an optimum condition for the proliferation of fibroblasts and epidermal cells, and then it falls off as the epidermis completely regenerates. On the other hand, the collagen sponge sheet assimilates in the living tissue after having played a general role of the dermis.
    Type: Grant
    Filed: June 6, 1985
    Date of Patent: February 10, 1987
    Assignee: Koken Co., Ltd.
    Inventors: Yoshimitsu Kuroyanagi, Teruo Miyata, Manabu Seno
  • Patent number: 4592864
    Abstract: An aqueous atelocollagen solution, which can be injected into living bodies as a medical material, has a pH value in the range from about 6.5 to about 8.0 and an osmolality in the range from about 250 to about 320 mOsm/KgH.sub.2 O, and contains a phosphate buffer solution, or glucose and a phosphate buffer solution, as an agent to adjust pH and osmolality within the ranges specified above. This aqueous atelocollagen solution can be prepared by dissolving atelocollagen in an aqueous acidic solution and adding the above-mentioned pH- and osmolality-adjusting agent to the resulting solution in such an amount as to adjust pH and osmolality of the final solution within the ranges mentioned above.
    Type: Grant
    Filed: July 25, 1984
    Date of Patent: June 3, 1986
    Assignee: Koken Co., Ltd.
    Inventors: Teruo Miyata, Toshio Taira
  • Patent number: 4565580
    Abstract: A substrate consisting essentially of regenerated collagen fibrils is provided which is in the form of a bead, or microsphere and comprises irregularly entangled regenerated collagen fibrils each having a diameter of 10-1000 m.mu. and an aqueous solution existing between the regenerated collagen fibrils, the content of the regenerated collagen fibrils being 20-0.01 wt. %. The substrate can be used for cell culture or for measuring adhesion activity of blood platelet.According to one method of manufacturing the collagen beads, an acidic aqueous collagen solution is dispersed in a water-immiscible organic solvent in the form of numerous droplets to form an emulsion, and the droplets are then coagulated by addition of a water-miscible organic solvent and an alkali to the emulsion.
    Type: Grant
    Filed: March 7, 1984
    Date of Patent: January 21, 1986
    Assignee: Koken Co., Ltd.
    Inventors: Teruo Miyata, Shinichi Namiki
  • Patent number: 4559304
    Abstract: A substratum for cell culture which comprises a chemically modified collagen rich in either positive or negative charges when under culture conditions. The substratum is prepared by modifying the amino groups or carboxyl groups of collagen. The chemically modified collagen enhances the adherence and proliferation of animal cells much more actively than unmodified collagen in the presence or absence of bovine fetus serum. The cultured animal cells can be detached efficiently from the chemically modified collagen. This allows for highly selective isolation and recovery of the cultured animal cells which can be accomplished without incurring any injury from the chemically modified collagen.
    Type: Grant
    Filed: August 8, 1983
    Date of Patent: December 17, 1985
    Assignee: Koken Co., Ltd.
    Inventors: Shunji Kasai, Toshihiro Akaike, Teruo Miyata
  • Patent number: 4406853
    Abstract: A novel collagen condom consists of isotropically-strong, crosslinked, regenerated fiber collagen. A method of preparation involves the steps of at least twice dipping a mandrel into an acidic collagen dispersion; slowly removing the mandrel under spinning conditions; neutralizing and drying the membrane between dippings; crosslinking the finally dried membrane while on the mandrel and removing the membrane from the mandrel.
    Type: Grant
    Filed: September 15, 1981
    Date of Patent: September 27, 1983
    Assignee: Collagen Development Corporation
    Inventor: Teruo Miyata
  • Patent number: 4349026
    Abstract: A novel collagen condom consists of isotropically-strong, crosslinked, regenerated fiber collagen. A method of preparation involves the steps of at least twice dipping a mandrel into an acidic collagen dispersion; slowly removing the mandrel under spinning conditions; neutralizing and drying the membrane between dippings; crosslinking the finally dried membrane while on the mandrel and removing the membrane from the mandrel.
    Type: Grant
    Filed: February 28, 1980
    Date of Patent: September 14, 1982
    Assignee: Collagen Development Corp.
    Inventor: Teruo Miyata
  • Patent number: 4314380
    Abstract: Artificial bone is prepared from animal bone treated for removal of organics, burned, baked and immersed in atelocollagen solution.
    Type: Grant
    Filed: September 26, 1980
    Date of Patent: February 9, 1982
    Assignee: Koken Co., Ltd.
    Inventors: Teruo Miyata, Taichiro Akiyama, Masayasu Furuse
  • Patent number: 4294241
    Abstract: Skin or wound dressings are prepared in gel or sheet form from enzyme-solubilized collagen and/or such chemically modified collagen. Improved sheet form dressing is prepared by tubular extrusion of such collagen gels.
    Type: Grant
    Filed: October 19, 1979
    Date of Patent: October 13, 1981
    Inventor: Teruo Miyata
  • Patent number: 4271070
    Abstract: Chemically-modified quaternary-structured fiber collagens of minimum molecular length, diameter and periodicity, and containing a relatively high positive electrostatic charge are claimed as hemostatic agents. Specific examples are guanidinated, esterified, and guanidinated-esterified collagen fibers of the type described.
    Type: Grant
    Filed: May 5, 1980
    Date of Patent: June 2, 1981
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Teruo Miyata, Albert L. Rubin, Kurt H. Stenzel
  • Patent number: 4268131
    Abstract: Soft contact lenses are made from purified fiber collagen and mixtures of such fiber with purified solubilized collagen.
    Type: Grant
    Filed: April 11, 1979
    Date of Patent: May 19, 1981
    Assignee: Opticol Corporation
    Inventors: Teruo Miyata, Albert L. Rubin, Kurt H. Stenzel, Michael W. Dunn
  • Patent number: 4264155
    Abstract: Improved soft contact lenses are made from collagen gels to which water-soluble organic polyhydroxy polymers are added, e.g. mucopolysaccharides, polyvinyl alcohols, etc.
    Type: Grant
    Filed: July 9, 1979
    Date of Patent: April 28, 1981
    Assignee: Opticol Corporation
    Inventor: Teruo Miyata
  • Patent number: 4260228
    Abstract: An improved collagen gel soft contact lens is prepared from an aldehyde-crosslinked, lens-shaped collagen gel containing a water-soluble, aliphatic, monomeric, polyhydroxy compound, e.g., glucose.
    Type: Grant
    Filed: January 21, 1980
    Date of Patent: April 7, 1981
    Assignee: Opticol Corporation
    Inventor: Teruo Miyata
  • Patent number: 4223984
    Abstract: Soft contact lenses are made from solubilized, defatted, transparent, cross-linked collagen, and/or chemically-modified collagen.
    Type: Grant
    Filed: April 4, 1979
    Date of Patent: September 23, 1980
    Assignee: Opticol Corporation
    Inventors: Teruo Miyata, Albert L. Rubin, Michael W. Dunn, Kurt H. Stenzel
  • Patent number: 4215200
    Abstract: Polymers of quaternary-structured collagen of minimum length, diameter and periodicity, and containing a relatively high positive electrostatic charge are claimed as hemostatic agents. Specific examples are guanidnated polymers of the type described, esterified polymers, and esterified-guanidinated polymers.
    Type: Grant
    Filed: October 2, 1978
    Date of Patent: July 29, 1980
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Teruo Miyata, Kurt H. Stenzel, Albert L. Rubin
  • Patent number: 4164559
    Abstract: Chemically-modified collagen membrane prepared at physiologic pH and soluble thereat provides a carrier for ophthalmic medication leaving no removable material after drug release.
    Type: Grant
    Filed: September 21, 1977
    Date of Patent: August 14, 1979
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Teruo Miyata, Albert L. Rubin, Kurt H. Stenzel, Michael W. Dunn